Heron shareholders approve increase in authorized shares to 400M and equity plan share expansion

HERON THERAPEUTICS, INC. /DE/

Authorized common stock increased by 175M shares from 225M to 400M; effective June 13, 2024.
2007 Plan shares increased by 7.5M (from 39.19M to 46.69M) and ESPP shares by 1.2M (from 2.225M to 3.425M).
All six director nominees elected with ~87M votes for each; auditor ratified with ~114M votes for.
Say-on-pay advisory vote passed with 72.7M for vs 14.4M against; broker non-votes of 29.2M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.